Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119367514 | 11936751 | 4 | F | 2015 | 20160811 | 20160121 | 20160818 | EXP | FR-SEATTLE GENETICS-2016SGN00061 | SEATTLE GENETICS | 0.00 | Y | 0.00000 | 20160818 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119367514 | 11936751 | 1 | PS | brentuximab vedotin | BRENTUXIMAB VEDOTIN | 1 | Intravenous (not otherwise specified) | 120 MG, UNK | Y | 125388 | 120 | MG | INJECTION | ||||||
| 119367514 | 11936751 | 2 | SS | CARBOPLATINE | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 580 MG, UNK | U | 0 | 580 | MG | |||||||
| 119367514 | 11936751 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 3600 MG, UNK | Y | 0 | 3600 | MG | INJECTION | ||||||
| 119367514 | 11936751 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | UNK | U | 0 | |||||||||
| 119367514 | 11936751 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | UNK, 3/WEEK | U | 0 | |||||||||
| 119367514 | 11936751 | 6 | C | VALACICLOVIR | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | UNK, BID | U | 0 | |||||||||
| 119367514 | 11936751 | 7 | C | ZOPICLONE | ZOPICLONE | 1 | Oral | UNK, QD | U | 0 | |||||||||
| 119367514 | 11936751 | 8 | C | LEDERFOLINE | LEUCOVORIN CALCIUM | 1 | Oral | UNK, QD | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119367514 | 11936751 | 1 | Peripheral T-cell lymphoma unspecified |
| 119367514 | 11936751 | 2 | Peripheral T-cell lymphoma unspecified |
| 119367514 | 11936751 | 3 | Peripheral T-cell lymphoma unspecified |
| 119367514 | 11936751 | 4 | T-cell lymphoma |
| 119367514 | 11936751 | 5 | Prophylaxis |
| 119367514 | 11936751 | 6 | Prophylaxis |
| 119367514 | 11936751 | 7 | Prophylaxis |
| 119367514 | 11936751 | 8 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119367514 | 11936751 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119367514 | 11936751 | Anaemia | |
| 119367514 | 11936751 | Aplasia | |
| 119367514 | 11936751 | Fatigue | |
| 119367514 | 11936751 | Febrile neutropenia | |
| 119367514 | 11936751 | Infection | |
| 119367514 | 11936751 | Neuropathy peripheral | |
| 119367514 | 11936751 | Neutropenia | |
| 119367514 | 11936751 | Pyrexia | |
| 119367514 | 11936751 | Stomatitis | |
| 119367514 | 11936751 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119367514 | 11936751 | 1 | 20151104 | 20160202 | 0 | |
| 119367514 | 11936751 | 2 | 20151105 | 20160202 | 0 | |
| 119367514 | 11936751 | 3 | 20151105 | 20160202 | 0 | |
| 119367514 | 11936751 | 4 | 20151105 | 20160202 | 0 |